Safety, tolerability and pharmacokinetics of 2g subcutaneous ceftriaxone as an alternative to intravenous administratio

Phase 4

Recruiting

• Conditions: Infection; Infection - Other infectious diseases; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12624000692538
• Lead Sponsor: Fiona Stanley Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-30
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Must meet all of:
- Age 18 years and older.
- Inpatient at Fiona Stanley Hospital
- Capacity to provide informed consent.
- Prescribed ceftriaxone 2g as part of their infection management plan.

Exclusion Criteria

Patients will not be eligible for participation if any of the following criteria are met:
- Patients deemed to be clinically unstable (defined as requiring High-level dependency care (HDU)/Intensive care (ICU) or having had a medical emergency team (MET) call within the preceding 24 hours)
- Patients with a history of cognitive impairment, intellectual disability or a mental illness that leads to the inability to provide informed consent
- Children < 18 years.
- History of anaphylaxis or serious adverse reaction to cephalosporins in past.

Study & Design

• Study Type: Interventional
• Study Design: Not specified